XML 55 R38.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The components and classification of stock-based compensation expense for fiscal years 2016, 2015 and 2014 were as follows (in thousands):
 
2016
 
2015
 
2014
Stock options
$
2,499

 
$
2,708

 
$
2,523

Restricted stock and units
5,909

 
6,668

 
6,417

401(k) stock contribution

 

 
4,246

Total stock-based compensation expense
$
8,408

 
$
9,376

 
$
13,186

 
 
 
 
 
 
Cost of sales
$
332

 
$
795

 
$
3,530

Selling, general and administrative expenses
6,246

 
7,510

 
7,923

Research, development and engineering costs, net
355

 
982

 
1,440

Other operating expenses, net (Note 13)
1,475

 
89

 
293

Total stock-based compensation expense
$
8,408

 
$
9,376

 
$
13,186

Schedule of Weighted Average Grant Date Fair Values of Restricted Stock Awards, Restricted Stock Units, and Performance-Based Restricted Stock Units
The following table provides the weighted average grant date fair values of the Company's restricted stock awards, restricted stock units and performance-based restricted stock units during fiscal years 2016, 2015 and 2014:
 
2016
 
2015
 
2014
Weighted average grant date fair values:
 
 
 
 
 
Restricted stock and restricted stock units
$
47.95

 
$
49.84

 
$
44.78

Performance-based restricted stock units
30.83

 
32.92

 
31.33

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table includes the weighted average grant date fair value of stock options granted to employees during fiscal years 2016, 2015 and 2014 and the related weighted average assumptions used in the Black-Scholes model:
 
2016
 
2015
 
2014
Fair value of options granted:
$
8.52

 
$
12.18

 
$
16.43

Assumptions:
 
 
 
 
 
Expected life of option from grant date (in years)
4.7

 
4.7

 
5.3

Risk-free interest rate
1.49
%
 
1.55
%
 
1.73
%
Expected volatility
27
%
 
26
%
 
39
%
Expected dividend yield
0
%
 
0
%
 
0
%
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes stock option activity under all stock-based compensation plans during the fiscal year ended December 30, 2016:
 
Number of
Stock
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(in years)
 
Aggregate
Intrinsic
Value
(in millions)
Outstanding at January 1, 2016
1,678,900

 
$
28.32

 
 
 
 
Granted
316,678

 
42.82

 
 
 
 
Exercised
(130,459
)
 
21.61

 
 
 
 
Forfeited or expired
(125,147
)
 
44.76

 
 
 
 
Adjustment due to Spin-off

 
(2.02
)
 
 
 
 
Outstanding at December 30, 2016
1,739,972

 
$
28.26

 
5.7
 
$
11.0

Vested and expected to vest at December 30, 2016
1,723,137

 
$
28.07

 
5.7
 
$
11.0

Exercisable at December 30, 2016
1,484,481

 
$
26.26

 
5.7
 
$
10.3

Schedule Of Stock Option Exercise Information
The following table provides certain information relating to the exercise of stock options during fiscal years 2016, 2015 and 2014 (in thousands):
 
2016
 
2015
 
2014
Intrinsic value
$
690

 
$
8,231

 
$
7,997

Cash received
2,821

 
6,583

 
8,278

Tax benefit realized

 
1,954

 
1,704

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
 
Time-Vested
Restricted Stock Units and Awards
 
Weighted
Average Grant Date
Fair Value
Nonvested at January 1, 2016
39,235

 
$
47.40

Granted
52,697

 
47.95

Vested
(40,304
)
 
49.64

Forfeited
(12,234
)
 
48.46

Nonvested at December 30, 2016
39,394

 
$
45.51

The following table summarizes performance-vested restricted stock and restricted stock unit activity under all stock-based compensation plans during the fiscal year ended December 30, 2016:
 
Performance-
Vested
Restricted Stock Units and Awards
 
Weighted
Average Grant Date
Fair Value
Nonvested at January 1, 2016
577,825

 
$
25.11

Granted
163,651

 
30.83

Vested
(254,340
)
 
16.19

Forfeited
(130,550
)
 
31.16

Nonvested at December 30, 2016
356,586

 
$
31.87